NASDAQ · Biotechnology
Immunitybio Inc (IBRX)
$6.02
-8.37%
40
In band
Moving averages
SMA 200$7.97-24.47%
Company profile
ImmunityBio, Inc., an immunotherapy company, develops a memory T-cell cancer vaccine to fight multiple types of tumors without the use of high-dose chemotherapy.
SectorHealthcare
IndustryBiotechnology
Market cap$7.10B
P/E ratioNone
EPS$-1.06
Beta0.174
Dividend yield0.00%
52-week high$12.43
52-week low$1.95
Similar stocks in Biotechnology
BNTX
BioNTech SE
RSI 32
VRTX
Vertex Pharmaceuticals Inc
RSI 43
CRSP
CRISPR Therapeutics AG
RSI 27
IOVA
Iovance Biotherapeutics Inc
RSI 31
BMRN
Biomarin Pharmaceutical Inc
RSI 64
TECH
Bio-Techne Corp
RSI 55
TARS
Tarsus Pharmaceuticals Inc
RSI 54
VKTX
Viking Therapeutics Inc
RSI 44
ATAI
ATAI Life Sciences N.V.
RSI 62
RXRX
Recursion Pharmaceuticals Inc - Class A
RSI 34
RSI alerts for IBRX
An email when IBRX closes below RSI 30 or above 70. Nothing else.
Data last updated 13 November 2026 at 12:52 AM EST